Presentation is loading. Please wait.

Presentation is loading. Please wait.

Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 

Published byAnis Bernice Hensley Modified over 5 years ago

Similar presentations

Presentation on theme: "Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? "— Presentation transcript:

1 Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern?  Abdul Ashish, Matthew Shaw, C. Winstanley, Martin J. Ledson, Martin J. Walshaw  Journal of Cystic Fibrosis  Volume 11, Issue 3, Pages (May 2012) DOI: /j.jcf Copyright © 2011 European Cystic Fibrosis Society Terms and Conditions

2 Fig. 1 Prevalence of strain resistance in patients infected Psa followed from 2004 to 2008. Journal of Cystic Fibrosis  , DOI: ( /j.jcf ) Copyright © 2011 European Cystic Fibrosis Society Terms and Conditions

3 Fig. 2 Antibiotic sensitivity profile of patients chronically infected with LES and other Psa strains attending Liverpool Adult CF Unit between 2004 and 2008.* Journal of Cystic Fibrosis  , DOI: ( /j.jcf ) Copyright © 2011 European Cystic Fibrosis Society Terms and Conditions

Download ppt "Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? "

Similar presentations

Cheryl Cameron, Mark W. Lodes, William M. Gershan 

Cheryl Cameron, Mark W. Lodes, William M. Gershan 
The prevalence of “risky behaviour” in adults with cystic fibrosis

The prevalence of “risky behaviour” in adults with cystic fibrosis
Achromobacter species in cystic fibrosis: Cross-infection caused by indirect patient-to- patient contact  C.R. Hansen, T. Pressler, W. Ridderberg, H.K.

Achromobacter species in cystic fibrosis: Cross-infection caused by indirect patient-to- patient contact  C.R. Hansen, T. Pressler, W. Ridderberg, H.K.
Treatment compliance in children and adults with Cystic Fibrosis

Treatment compliance in children and adults with Cystic Fibrosis
Megan W. France, Mary E. Dodd, John R. Govan, Catherine J. Doherty, A

Megan W. France, Mary E. Dodd, John R. Govan, Catherine J. Doherty, A
P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham 

P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham 
Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients  Helle Krogh Johansen, Samuel.

Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients  Helle Krogh Johansen, Samuel.
Is infection with hypermutable Pseudomonas aeruginosa clinically significant?  Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir 

Is infection with hypermutable Pseudomonas aeruginosa clinically significant?  Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir 
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J

R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis 

Abaigeal D. Jackson, Christopher H. Goss  Journal of Cystic Fibrosis 
Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection—A.

Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection—A.
A. Mirakhur, M.J. Gallagher, M.J. Ledson, C.A. Hart, M.J. Walshaw 

A. Mirakhur, M.J. Gallagher, M.J. Ledson, C.A. Hart, M.J. Walshaw 
Epidemic Pseudomonas aeruginosa infection in patients with cystic fibrosis is not a risk factor for poor clinical Outcomes following lung transplantation 

Epidemic Pseudomonas aeruginosa infection in patients with cystic fibrosis is not a risk factor for poor clinical Outcomes following lung transplantation 
Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands  R.W. Brimicombe, L. Dijkshoorn, T.J.K.

Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands  R.W. Brimicombe, L. Dijkshoorn, T.J.K.
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.

Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,

Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 

Laura Viviani, Baroukh M. Assael, Eitan Kerem 
A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study  Maret L. Maliniak, Arlene A.

A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study  Maret L. Maliniak, Arlene A.
Cirrhosis and other liver disease in cystic fibrosis

Cirrhosis and other liver disease in cystic fibrosis
Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection  Marita Gilljam, Henrik Scherstén, Martin Silverborn, Bodil.

Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection  Marita Gilljam, Henrik Scherstén, Martin Silverborn, Bodil.

Similar presentations

Ads by Google